Apligraf: Difference between revisions

From IntactiWiki
Jump to navigation Jump to search
WikiAdmin (talk | contribs)
Created page with "{{Construction Site}} right|thumb| Apligraf is a synthetic skin created from harvested foreskins.<ref> {{cite web | url = http://www.apligraf.com..."
 
WikiAdmin (talk | contribs)
m wikify skin
 
(11 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Construction Site}}
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] -->
'''Apligraf''' is a synthetic [[skin]] created from harvested foreskins.<ref>{{REFweb
|quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins
|url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
|title=Apligraf: How Is It Made?
|last=
|first=
|publisher=Organogenesis
|date=
|accessdate=2011-03-06
}}</ref> It is [[FDA]] approved,<ref>{{REFweb
|quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
|url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
|title=Apligraf
|last=
|first=
|publisher=Organogenesis
|date=
|accessdate=2011-03-06
}}</ref> and it is made and sold by [[Organogenesis]], a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.


[[Image:Alloderm-logo.jpg|right|thumb|]]
== Apligraph Oral ==
Apligraf is a synthetic skin created from harvested foreskins.<ref>
{{cite web
| url = http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
| title = Apligraf: How Is It Made?
| accessdate = 2011-03-06
| publisher = Organogenesis
| quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins
}}
</ref> It is [[FDA]] approved,<ref>
{{cite web
| url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
| title = Apligraf
| accessdate = 2011-03-06
| publisher = Organogenesis
| quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
}}
</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.


==Apligraph Oral==
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
|last=
|first=
|url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf
|title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
|date=2011-11-17
|publisher=FDA
|quote=
|accessdate=2011-12-20
}}</ref>
<!-- 404: Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf -->
{{REF}}


Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{cite web | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | accessdate = 2011-12-20 | date = November 2011}}</ref>
[[Category:Foreskin product]]
[[Category:Financial gain]]


Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
[[Category:From CircLeaks]]
 
[[Category:From IntactWiki]]
==<small>References</small>==
<div class='references-small'>
<references/>
</div>
 
[[Category:Foreskin Products]]
[[Category:Financial Gain]]
[[Category:CircLeaks]]


[[Category:Construction Site]]
[[de:{{FULLPAGENAME}}]]
[[Category:From IntactWiki]]

Latest revision as of 14:56, 27 December 2021

Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.

Apligraph Oral

Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]

References

  1. REFweb Apligraf: How Is It Made?, Organogenesis. Retrieved 6 March 2011.
    Quote: Human keratinocytes and fibroblasts are derived from neonatal foreskins
  2. REFweb Apligraf, Organogenesis. Retrieved 6 March 2011.
    Quote: Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
  3. REFnews (17 November 2011)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.